Suppr超能文献

用于诊断路易体病的碘-间位碘代苄胍心肌闪烁显像摄取指数

Uptake Index of I-metaiodobenzylguanidine Myocardial Scintigraphy for Diagnosing Lewy Body Disease.

作者信息

Kamiya Yoshito, Ota Satoru, Okumiya Shintaro, Yamashita Kosuke, Takaki Akihiro, Ito Shigeki

机构信息

Graduate School of Health Sciences, Kumamoto University, Kumamoto, Japan.

Fujifilm RI Pharma Co., Ltd., Tokyo, Japan.

出版信息

Asia Ocean J Nucl Med Biol. 2017 Winter;5(1):37-43. doi: 10.22038/aojnmb.2016.7972.

Abstract

OBJECTIVES

Iodine-123 metaiodobenzylguanidine (I-MIBG) myocardial scintigraphy has been used to evaluate cardiac sympathetic denervation in Lewy body disease (LBD), including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). The heart-to-mediastinum ratio (H/M) in PD and DLB is significantly lower than that in Parkinson's plus syndromes and Alzheimer's disease. Although this ratio is useful for distinguishing LBD from non-LBD, it fluctuates depending on the system performance of the gamma cameras. Therefore, a new, simple quantification method using I-MIBG uptake analysis is required for clinical study. The purpose of this study was to develop a new uptake index with a simple protocol to determine I-MIBG uptake on planar images.

METHODS

The I-MIBG input function was obtained from the input counts of the pulmonary artery (PA), which were assessed by analyzing the PA time-activity curves. The heart region of interest used for determining the H/M was used for calculating the uptake index, which was obtained by dividing the heart count by the input count.

RESULTS

Forty-eight patients underwent I-MIBG chest angiography and planar imaging, after clinical feature assessment and tracer injection. The H/M and I-MIBG uptake index were calculated and correlated with clinical features. Values for LBD were significantly lower than those for non-LBD in all analyses (P<0.001). The overlapping ranges between non-LBD and LBD were 2.15 to 2.49 in the H/M method, and 1.04 to 1.22% in the uptake index method. The diagnostic accuracy of the uptake index (area under the curve (AUC), 0.98; sensitivity, 96%; specificity, 91%; positive predictive value (PPV), 90%; negative predictive value (NPV), 93%; and accuracy, 92%) was approximately equal to that of the H/M (AUC, 0.95; sensitivity, 93%; specificity, 91%; PPV, 90%; NPV, 93%; and accuracy, 92%) for discriminating patients with LBD and non-LBD.

CONCLUSION

A simple uptake index method was developed using I-MIBG planar imaging and the input counts determined by analyzing chest radioisotope angiography images of the PA. The diagnostic accuracy of the uptake index was approximately equal to that of the H/M for discriminating patients with LBD and non-LBD.

摘要

目的

123I-间碘苄胍(I-MIBG)心肌闪烁显像已用于评估路易体病(LBD),包括帕金森病(PD)和路易体痴呆(DLB)中的心脏交感神经去神经支配情况。PD和DLB中的心纵隔比(H/M)显著低于帕金森叠加综合征和阿尔茨海默病中的该比值。尽管该比值有助于区分LBD与非LBD,但它会因γ相机的系统性能而波动。因此,临床研究需要一种使用I-MIBG摄取分析的新的、简单的定量方法。本研究的目的是开发一种具有简单方案的新摄取指数,以确定平面图像上的I-MIBG摄取情况。

方法

I-MIBG输入函数通过肺动脉(PA)的输入计数获得,PA的输入计数通过分析PA时间-活性曲线来评估。用于确定H/M的心感兴趣区用于计算摄取指数,摄取指数通过将心脏计数除以输入计数获得。

结果

48例患者在进行临床特征评估和示踪剂注射后接受了I-MIBG胸部血管造影和平面显像。计算了H/M和I-MIBG摄取指数,并将其与临床特征相关联。在所有分析中,LBD的值均显著低于非LBD的值(P<0.001)。H/M法中非LBD与LBD之间的重叠范围为2.15至2.49,摄取指数法中为1.04至1.22%。摄取指数的诊断准确性(曲线下面积(AUC)为0.98;敏感性为96%;特异性为91%;阳性预测值(PPV)为90%;阴性预测值(NPV)为93%;准确性为92%)与H/M法(AUC为0.95;敏感性为93%;特异性为91%;PPV为90%;NPV为93%;准确性为92%)在区分LBD和非LBD患者方面大致相当。

结论

利用I-MIBG平面显像和通过分析PA胸部放射性核素血管造影图像确定的输入计数,开发了一种简单的摄取指数方法。摄取指数的诊断准确性在区分LBD和非LBD患者方面与H/M法大致相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2754/5221684/0aa3dff1bc00/AOJNMB-5-37-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验